Mackwell Health has announced a partnership with GE Current, to collaborate in the field of LED UV disinfection technology. The partnership will extend Current’s ground-breaking 365DisInFx UV Technology to the European, Middle Eastern and Australia/New Zealand markets.

The 365DisInFx UV technology leverages LEDs to help reduce the potential spread of certain common infection-causing pathogens. This allows for continuous disinfection in spaces while occupants are present.

"We are delighted to announce this partnership with GE Current," said Nick Brangwin, CEO of Mackwell Group. "It was clear as soon as we began discussions that our two companies share a common philosophy, which is to exploit the vast potential of UV technology, but in a responsible way, backed by science and with a comprehensive body of evidence. Our partnership will allow many more people across the world to be kept much safer from infectious disease.”

The 365DisInFx UVC solutions can help reduce viruses in air. Current’s latest testing with SARS-CoV-2 resulted in 90% inactivation of the aerosolized virus within 2 hours. The test was conducted in an 36m3 room equipped with twelve 365DisInFx™ LPU prototype devices, configured for 8-hour Permissible Exposure Time (PET) at head height. SARS-CoV-2 Isolate USA-CA1/2020 was used in this testing, and results are expected to be representative of other SARS-CoV-2 isolates or strains.

"We are excited to align with Mackwell Health to bring 365DisInFx technology to more customers across the globe. We continue to invest in technology and innovation and enable more partners to deliver products that are solving real world challenges,” said Manish Bhandari, CEO of GE Current.